RxDoctor Payments Data

Jonathan Haft, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Ann Arbor, MINPI 1922190313

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Abbott at 45.7% of the total. Reporting peaked in 2024 at $7,362 and has fallen 99.0% since, to $74 in 2025.

$16,640in general payments, 2019–2025

Across 50 payments — averaging $332.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$8K
  • Transmedics, Inc.$4K
  • Medtronic$3K
  • Abiomed$1K
  • Getinge USA Sales, LLC$75
  • Baxter Healthcare$18
$27,984in research payments, 2019–2025

Across 6 payments — averaging $4664.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$20K
  • Medtronic$8K

What the payments were for

  • Consulting fees$5,70034%
  • Speaking & faculty fees$3,20019%
  • Travel & lodging$5,95236%
  • Food & beverage$1,78711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott28$7,608
Transmedics, Inc.3$4,134
Medtronic(2 entities)7$3,492
Abiomed8$1,311
Getinge USA Sales, LLC3$75
Baxter Healthcare1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,640 in reported general payments places this provider in the 75th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan

Medicare billing

Part B allowed, 2024
$115,096
Medicare patients
64
Services billed
172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mexiletine Hcl23$5,393
Enoxaparin Sodium11$2,185
Amiodarone Hcl30$2,072
Potassium Chloride26$1,593
Digoxin62$1,485
Torsemide33$1,298
Warfarin Sodium44$1,296
Omeprazole72$1,289
Metoprolol Succinate35$930
Spironolactone64$736
Losartan Potassium12$363
Atorvastatin Calcium21$259
Lisinopril15$85
Amoxicillin19$16

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →